Your browser doesn't support javascript.
loading
Cogan syndrome: Descriptive analysis and clinical experience of 7 cases diagnosed and treated in two third level hospitals. / Síndrome de Cogan: análisis descriptivo y experiencia clínica de 7 casos diagnosticados y tratados en 2 hospitales de tercer nivel.
Almorza Hidalgo, Tomás; García González, Alfredo Javier; Castañeda, Santos; Tomero, Eva G; Pablos Álvarez, Jose Luis.
Afiliación
  • Almorza Hidalgo T; Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, España. Electronic address: tomas.almorza@hotmail.com.
  • García González AJ; Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, España.
  • Castañeda S; Servicio de Reumatología, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, España; Departamento de Medicina, Universidad Autónoma de Madrid, Madrid, España.
  • Tomero EG; Servicio de Reumatología, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, España; Departamento de Medicina, Universidad Autónoma de Madrid, Madrid, España.
  • Pablos Álvarez JL; Servicio de Reumatología, Hospital Universitario 12 de Octubre, Madrid, España; Universidad Complutense de Madrid, Madrid, España.
Reumatol Clin (Engl Ed) ; 17(6): 318-321, 2021.
Article en En, Es | MEDLINE | ID: mdl-32571733
ABSTRACT

OBJECTIVE:

Cogan's syndrome (CS) is an inflammatory disease classified as variable vessel vasculitis. It is a rare disease with few published series, and therefore we reviewed our experience in the last ten years in two centres. MATERIALS AND

METHODS:

Description of 7 diagnosed cases of CS, according to the classification criteria (typical or atypical), their clinical manifestations, treatments used and their complications. A comparative analysis was performed with the series and cases described in the literature.

RESULTS:

Seven cases were included, three men and four women, with a mean age at diagnosis of 43 years, and an average disease duration of 47 months. Five patients met the typical characteristics according to the 1980 classical criteria, the rest being atypical cases, one due to the absence of interstitial keratitis and another due to a period between the onset of ocular and auditory-vestibular clinical symptoms greater than two years. All received immunosuppressants, methotrexate being the most commonly used, followed by azathioprine. In 5 cases, biological drugs were used, infliximab in 4 times and 2 tocilizumab. One patient died from bacterial endocarditis and septic shock.

CONCLUSION:

The characteristics of the series presented are like those published to date, with clinical differences mainly in the involvement of large vessels. Given the low frequency, it seems necessary to create multicentre records to improve the evidence regarding the management of patients with CS.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En / Es Revista: Reumatol Clin (Engl Ed) Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En / Es Revista: Reumatol Clin (Engl Ed) Año: 2021 Tipo del documento: Article